Legend Biotech Corp (STU:9LB)
€ 39 0 (0%) Market Cap: 7.15 Bil Enterprise Value: 6.33 Bil PE Ratio: 0 PB Ratio: 7.06 GF Score: 61/100

Legend Biotech Corp R&D Day Transcript

Oct 03, 2022 / 02:00PM GMT
Release Date Price: €41.6 (+2.46%)
Joanne Choi
Legend Biotech Corporation - Senior Manager of IR

All right. Good morning, everyone, and thank you for being here for our Second Research and Development Day. I'm Joanne Choi on the Investor Relations team here at Legend.

Before we kick things off, I do need to mention that today's webcast contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from the information being presented here today. These are discussed in our filings with the SEC and can be found under the Investors Section of our company website.

Today's presentation will begin with an update with the latest developments in our CARTITUDE Program. Afterwards, we will take a coffee break, and then move into our R&D pipeline before opening up for Q&A.

And now, I will turn the meeting over to our CEO, Dr. Ying Huang. Thank you.

Ying Huang
Legend Biotech Corporation - CEO & Director

Well, good morning, everyone. It's really nice to see a full room of people here. And also, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot